US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

41.04

+0.62001.53%

Volume:19.56K

Turnover:800.00K

Market Cap:305.75M

PE:- -

High:41.20

Open:40.52

Low:40.52

Close:40.42

52wk High:43.44

52wk Low:23.90

Shares:7.45M

Float Shares:7.45M

Volume Ratio:2.34

T/O Rate:0.26%

Dividend:0.28

Dividend Rate:0.69%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

THOMSON REUTERS

Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website

THOMSON REUTERS

Moderna Appoints Juan Andres as Chief Operating Officer

Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup

Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60

THOMSON REUTERS

Sagimet Biosciences reports results from Phase 3 ASC40-304 OLE clinical trial

Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026

Moderna sinks 4% to $195.42 after Citi downgrades to Sell

Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Liver safety concerns emerge for Bristol Myers’ admilparant, says Wells Fargo

Twist Bioscience (TWST) Gets a Buy from Leerink Partners

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

CSPC Launches Phase Ib Trial of Obesity Biologic JMT206 in China

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)

Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Sells USD 743,436 in Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketf.com/stock/IDNA/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":41.04,"timestamp":1791553685170,"preClose":40.42,"halted":0,"volume":19560,"delay":0,"changeRate":0.015338941118258224,"floatShares":7450000,"shares":7450000,"eps":0,"marketStatus":"Trading","change":0.62,"latestTime":"10-09 09:48:38 EDT","open":40.52,"high":41.2,"low":40.52,"amount":800004,"amplitude":0.016823,"askPrice":41.16,"askSize":400,"bidPrice":40.9,"bidSize":400,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":40.42,"sharesOutstanding":5100000,"nav":40.752915,"aum":307684508.25,"dividendRate":0.006871,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":40.42,"preClose":40.42,"latestTime":"07:38 EDT","volume":3,"amount":121.22320199999999,"timestamp":1791545933537,"change":0,"changeRate":0,"amplitude":0.000495},"postHourTrading":{"tag":"盘后","latestPrice":40.42,"preClose":40.42,"latestTime":"19:56 EDT","volume":5346,"amount":216103.66,"timestamp":1791503775220,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.338672,"impliedVol":0.3149,"impliedVolPercentile":0.8406},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":7450000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.338672,"shares":7450000,"dividePrice":0.282,"high":41.2,"amplitude":0.016823,"preClose":40.42,"low":40.52,"week52Low":23.9,"pbRate":"--","week52High":43.44,"institutionHeld":0,"latestPrice":41.04,"eps":0,"divideRate":0.006871,"volume":19560,"delay":0,"ttmEps":0,"open":40.52,"prevYearClose":26.19,"prevWeekClose":41.65,"prevMonthClose":42.32,"prevQuarterClose":42.32,"fiveDayClose":41.65,"twentyDayClose":38.06,"sixtyDayClose":32.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671206085","title":"Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206085?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:15","pubTimestamp":1790766915,"startTime":"0","endTime":"0","summary":"Citigroup downgraded Moderna, Inc. ($MRNA) from Neutral/High Risk to Sell/High Risk after the biotech stock’s sharp two-month rally, arguing that o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/citi-downgrades-moderna-stock-after-222-rally-calls-oncology-expectations-unrealistic?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/citi-downgrades-moderna-stock-after-222-rally-calls-oncology-expectations-unrealistic?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","WDNA","MRNA","BK4548","BK4532","BK4501","BK4585","MRNX","BK4568","LGHT","NVIB","MRNY","BK4551","IDNA","XBIX","BK4534","BK4139","BK4533","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206126","title":"Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206126?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:12","pubTimestamp":1790766720,"startTime":"0","endTime":"0","summary":"Biotech can't generate the revenue that investors expect, says Wall Street firmModerna was the target of a sell recommendation by Citi.After rallying almost seven-fold this year, Citi is now advising ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4139","LU0889565916.HKD","LGHT","LU0882574055.USD","LU0289739699.SGD","LU2023250504.SGD","BBH","BK4588","LU0109394709.USD","LU2468319806.SGD","BK4568","LU2362540622.SGD","GNOM","BK4551","MRNX","BK4585","LU0053666078.USD","LU2106854487.HKD","IBB","LU2362541513.USD","LU0114720955.EUR","LU1974910355.USD","BK4501","BK4533","LU1917777945.USD","LU0823416689.USD","REGN","TBXU","IBBQ","IDNA","LU2237438978.USD","LU0058720904.USD","LU0823434583.USD","LU0823434740.USD","LU0320765992.SGD","BK4534","LU2324357040.USD","BK4548","LU2089984988.USD","MRNA","ISBC","LU2362541273.HKD","BK4211","MRNY","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206332","title":"Moderna Adds Chief Operating Officer Role as Company Expands into Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206332?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:02","pubTimestamp":1790766162,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0LB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","MRNA","BK4501","BK4585","BK4139","BK4533","MRNY","BK4534","BK4551","GNOM","BK4588","IDNA","BK4532","LGHT","MRNX","WDNA","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671063402","title":"Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2671063402","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671063402?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:02","pubTimestamp":1790766162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0LB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","MRNA","BK4533","MRNX","BK4501","MRNY","BK4585","BK4534","BK4548","BK4551","WDNA","BK4139","BK4532","BK4588","IDNA","LGHT","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206369","title":"Moderna Appoints Juan Andres as Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206369","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206369?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:02","pubTimestamp":1790766128,"startTime":"0","endTime":"0","summary":"Moderna appoints Juan Andres as chief operating officerModerna created a Chief Operating Officer role as it scales operations for a broader oncology push.Juan Andres will return as Chief Operating Off","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL2q7MsY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4534","BK4585","BK4588","BK4568","IDNA","MRNA","MRNX","WDNA","BK4548","BK4501","BK4532","BK4139","BK4533","BK4551","LGHT","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671720531","title":"Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2671720531","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671720531?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:32","pubTimestamp":1790764320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","BK4532","BK4534","BK4551","BK4588","MRNY","WDNA","BK4501","BK4533","BK4548","MRNA","BK4585","MRNX","BK4568","GNOM","IDNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671342203","title":"Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2671342203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671342203?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:16","pubTimestamp":1790763366,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","BK4534","IDNA","GNOM","BK4585","MRNX","BK4588","WDNA","BK4533","BK4532","BK4139","MRNA","BK4501","MRNY","BK4548","BK4551","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203699","title":"Sagimet Biosciences reports results from Phase 3 ASC40-304 OLE clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203699","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671203699?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:10","pubTimestamp":1790763034,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) announced positive 52-week results from the Phase 3 ASC40-304 OLE clinical trial of denifanstat in patients with moderat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-reports-results-from-phase-3-asc40-304-ole-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-reports-results-from-phase-3-asc40-304-ole-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","HYLG","BK4139","SGMT","GDOC","NVIB","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671087702","title":"Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671087702","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671087702?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:00","pubTimestamp":1790762400,"startTime":"0","endTime":"0","summary":"In the Phase 3 open-label extension clinical trial (OLE), patients with moderate to severe acne received denifanstat for up to 52 weeks, including prior placebo patientsDenifanstat showed progressive ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371663/0/en/sagimet-announces-positive-full-52-week-results-from-license-partner-ascletis-phase-3-open-label-extension-clinical-trial-of-denifanstat-in-acne-presented-at-eadv-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IGA","MEDX","GDOC","NVIB","IDNA","SD","BK4213","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208459","title":"Moderna sinks 4% to $195.42 after Citi downgrades to Sell","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208459","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208459?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:55","pubTimestamp":1790762117,"startTime":"0","endTime":"0","summary":"05:50 EDT Moderna (MRNA) sinks 4% to $195.42 after Citi downgrades to Sell Published first on TheFly – the ultimate source for real-time, market-mo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-sinks-4-to-195-42-after-citi-downgrades-to-sell-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-sinks-4-to-195-42-after-citi-downgrades-to-sell-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDNA","GNOM","BK4533","BK4548","IDNA","MRNA","MRNX","MRNY","BK4534","BK4551","BK4532","BK4568","BK4501","BK4139","BK4588","BK4585","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171282700","title":"Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1171282700","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171282700?lang=en_us&edition=fundamental","pubTime":"2026-09-30 12:07","pubTimestamp":1790741227,"startTime":"0","endTime":"0","summary":"The Hang Seng Index fell 0.04%, down 10 points, to 24,513 points; the Hang Seng Tech Index declined 0.15%.Morning trading turnover in Hong Kong stocks reached HK$88.7 billion.mRNA-related shares...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["83115","HSImain","03115","BK1592","BK1515","LU0828237940.HKD","BK1524","BK4501","02837","688185","HK0000320223.HKD","02723","URNJ","BK4551","BK1137","03088","BK1576","BK1594","03032","BK1178","603127","002821","07226","WDNA","HTImain","LU0181495838.USD","HK0000306685.HKD","00625","09067","07200","LGHT","02800","09115","BK1574","MRNA","01164","03037","BK1518","BK4534","BK1191","BK4585","09088","IE0034224299.USD","600547","82800","HK0000306701.USD","03417","06802","02362","MRNY","BK1161","BK1555","03423","BK4532","000002","HSTECH","LU0140636845.USD","03347","HHImain","BK1507","MRNX","03033","BK4568","03067","06185","BK1521","300347","06821","HK0000320264.USD","BK4588","07552","07500","BK4548","BK1206","BK1198","07300","BK1583","BK4533","IDNA","01860","BK1544","01548","01787","BK1240","MCHmain","HSI","LU1188198961.HKD","BK1141","BK1586","06127","02202","LU0463099449.HKD","BK1590","LU1831875114.USD","03419","513600","BK4139","GNOM","LU0326950275.SGD","BK1613","02833","LU0244354667.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671942228","title":"DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2671942228","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671942228?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:29","pubTimestamp":1790720940,"startTime":"0","endTime":"0","summary":"Chtillon, France, September 29, 2026 DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for theVIASKIN Peanut Patch in Children Aged 4-7 Years  TheBLAis supportedbyther","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3371452/0/en/dbv-technologies-announces-submission-of-biologics-license-application-to-u-s-fda-for-the-viaskin-peanut-patch-in-children-aged-4-7-years.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","GDOC","HYLG","BK4585","NVIB","MEDX","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671324755","title":"Moderna Inc. Stock Climbs 3.1%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2671324755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671324755?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:35","pubTimestamp":1790714100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 3.1% to $203.46 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,797.54 and Dow Jones Industrial Average falling 0.3% to 51,349.92.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $202.67, which the company achieved on September 25th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.6% to $267.57, Pfizer Inc. remained unchanged, and Gilead Sciences Inc. fell 0.61% to $151.28.Trading volume totaled 13.1 million, compared to the 50-day average of 19.2 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU0965509283.SGD","IDNA","MRNY","BK4551","LU1571399168.USD","LU1430594728.SGD","LU0114720955.EUR","LU0058720904.USD","TMED","WDNA","LU1674673691.USD","LU0882574055.USD","LU1066053197.SGD","LU2468319806.SGD","LU2324357040.USD","MEDI","LU1934455194.USD","BBH","IBBQ","BK4534","LU1839511570.USD","MRNA","LU0320765992.SGD","LU0861579265.USD","LU1057294990.SGD","IE00B3T34201.USD","LU1934455277.USD","MRNX","LU0122379950.USD","BIB","IE00BKVL7J92.USD","BK4550","BMED","LGHT","LU0965508806.USD","LU0889565916.HKD","BK4533","LU0859254822.USD","BK4585","LU0289739699.SGD","LU0965509010.AUD","BK4501","BK4578","GNOM","LU2089984988.USD","IBB","GILD","TBXU","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671054242","title":"Liver safety concerns emerge for Bristol Myers’ admilparant, says Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2671054242","media":"TIPRANKS","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671054242?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:10","pubTimestamp":1790712632,"startTime":"0","endTime":"0","summary":"Wells Fargo says admilparant protocol documents on EU clinical trials suggest liver safety issues in blinded Phase 3 data. While the firm says “we ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liver-safety-concerns-emerge-for-bristol-myers-admilparant-says-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liver-safety-concerns-emerge-for-bristol-myers-admilparant-says-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","LU1791807156.HKD","LU2361045086.USD","IDNA","IE00B7SZLL34.SGD","LU0211328371.USD","MEDX","LU0289960550.SGD","LU0310799852.SGD","LU1506573853.SGD","LU0942090050.USD","PGF","KBWB","LU1894683264.USD","IE000M9KFDE8.USD","BK4126","LU0175139822.USD","LU0029864427.USD","LU1280957306.USD","IE00B19Z3B42.SGD","TFNS","MYE","IE00B19Z3581.USD","LU0310800379.SGD","LU0971096721.USD","LU1668664300.SGD","LU0211327993.USD","BK4582","LU2236285917.USD","LU0048573561.USD","LU0154236417.USD","BMED","LU0980610538.SGD","LU1363072403.SGD","BK4585","LU0251131958.USD","BK4588","FTXO","BK4559","HYLG","LU0052756011.USD","LU0320765489.SGD","LU1894683348.USD","NVIB","LU1035773651.USD","LU0162691827.USD","BK4504","IYF","LU0267386448.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221213","title":"Twist Bioscience (TWST) Gets a Buy from Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671221213?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:55","pubTimestamp":1790686553,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Puneet Souda maintained a Buy rating on Twist Bioscience today and set a price target of $190.00. Souda covers the Healthc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/twist-bioscience-twst-gets-a-buy-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/twist-bioscience-twst-gets-a-buy-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARKG","IDNA","BK4139","WDNA","GNOM","BK4588","TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671949211","title":"NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2671949211","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671949211?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683200,"startTime":"0","endTime":"0","summary":"- SPINOZA is studying obicetrapib in adults with biomarker evidence suggestive of preclinical Alzheimer’s disease who do not have noticeable memory or functional symptoms- - The study will evaluate ch","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370754/0/en/newamsterdam-pharma-doses-first-participant-in-phase-2b-spinoza-trial-evaluating-obicetrapib-in-preclinical-alzheimer-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BMED","CDR","NVIB","HYLG","IDNA","BK4080","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671213179","title":"CSPC Launches Phase Ib Trial of Obesity Biologic JMT206 in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2671213179","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671213179?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:07","pubTimestamp":1790676452,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group ( ($HK:1093) ) has shared an update. CSPC Pharmaceutical Group has initiated a Phase Ib clinical trial in China for JMT20...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cspc-launches-phase-ib-trial-of-obesity-biologic-jmt206-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cspc-launches-phase-ib-trial-of-obesity-biologic-jmt206-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","HYLG","GDOC","IDNA","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671829804","title":"Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671829804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671829804?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:00","pubTimestamp":1790658033,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Inventiva (IVA) and Moderna (MRNA). Inventiva (IVA...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-and-moderna-mrna-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-and-moderna-mrna-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA","LU0128526141.USD","LU0029874061.USD","BK4139","MRNX","HCSG","MRNY","BK4534","BK4588","WDNA","BK4548","BK4551","XLV","LGHT","BK4581","BK4585","IDNA","BK4533","GNOM","BK4568","MRNA","BK4137","LABU","BK4501","BK4532","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145285517","title":"Judge Rejects Pfizer, BioNTech, and Moderna Bid to Dismiss Monsanto mRNA Patent Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=1145285517","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145285517?lang=en_us&edition=fundamental","pubTime":"2026-09-29 10:39","pubTimestamp":1790649592,"startTime":"0","endTime":"0","summary":"A federal judge in Delaware rejected a request on Monday from Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) to dismiss a lawsuit brought against them by Monsanto, a unit of German...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210536198.USD","IE000WAW04H5.SGD","IE0034235303.USD","LU0432979614.USD","IE0002270589.USD","LU0943347566.SGD","SG9999001176.USD","LU1718418525.SGD","LU0787776722.HKD","LU0661504455.SGD","LU2602419157.SGD","LU2129689514.USD","LU1935042991.SGD","IE0002141913.USD","LU1066051225.USD","LU1551013342.USD","JDOC","LU0289961442.SGD","LU0053666078.USD","BMED","LU0868494617.USD","LU1496350502.SGD","BK4550","LU1989771016.USD","LU2089984988.USD","LU2236285917.USD","LU2129689605.HKD","LU2505996509.AUD","FTXH","IE00BSNM7G36.USD","LU0320765646.SGD","LU0072461881.USD","BK4534","BK4599","IE00B19Z3581.USD","BK4588","LU2403377893.USD","IE00B3PB1722.GBP","LU0689626769.HKD","LU0162691827.USD","TRUH","IE000SO60NU8.SGD","IYH","LU0985481810.HKD","BK4585","LU0098860793.USD","IE00BGHQF631.EUR","MEDX","IE00B19Z3B42.SGD","LU1983299246.USD","SG9999013999.USD","LU1228905540.USD","OZEM","IE000MB6IJN5.SGD","IE00B7SZLL34.SGD","LU0234572021.USD","LU0912757837.SGD","LU0345769128.USD","BK4535","LU0058720904.USD","LU1162221912.USD","BK4592","LU1228905037.USD","LU0124676726.USD","IE00B4R5TH58.HKD","LU0426417589.USD","LU0949170772.SGD","LU1551013425.SGD","BK4504","LU1883839398.USD","LU2456880835.USD","MRNX","IE000BZT7R73.USD","IE000M9KFDE8.USD","LU2750360641.GBP","BK4581","PFE","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU1506573853.SGD","BK4533","LU2487616109.SGD","LU0738911758.USD","SG9999011175.SGD","IE00BVYPNV92.GBP","LU0114720955.EUR","LU1267930813.SGD","LU0069063385.USD","LU1629891620.HKD","IE00BFTCPJ56.SGD","MRNA","LU1032466523.USD","IE0009355771.USD","LU0553294199.USD","LU1032955483.USD","BNTX","BK4551","LU0306806265.USD","LU0882574055.USD","IE000F7OJYX1.SGD","VHT","LU0345769631.USD","IHE","LU1043141396.HKD","LU2133065610.SGD","LU0456855351.SGD","LU1778281490.HKD","LU0170899867.USD","IE00BBT3K403.USD","LU2750360997.AUD","LU2471134523.USD","LU1057294990.SGD","IE00B42XCP33.USD","LU2756315664.SGD","FHLC","LU1244550494.USD","LU1732799900.SGD","LU0820562030.AUD","LU0640476718.USD","LU1003077747.HKD","LU2023250330.USD","BK4559","LU2896262040.SGD","LU1291159041.SGD","BK4501","BK4532","LU0689472784.USD","MRNY","LU1430594728.SGD","LU2430703178.SGD","LU1929549753.HKD","LU0210528500.USD","LU0070217475.USD","LU0203347892.USD","BAYRY","LU2471134879.HKD","LU2592432038.USD","SG9999001440.SGD","LU0795875169.SGD","LU0321505439.SGD","LU0225284248.USD","SG9999001176.SGD","LU1023059063.AUD","LU2112291526.USD","LU1914381329.SGD","LU2471134796.USD","LU1121112475.USD","LU2347655156.SGD","LU0683600562.USD","LU1066051498.USD","LU0203345920.USD","LU0820561909.HKD","WDNA","XLV","LU0345770308.USD","SGXZ57979304.SGD","LU1280957306.USD","GDOC","SG9999002232.USD","LU1221951129.SGD","IE00BDGV0183.EUR","LU1674673691.USD","LU1894683264.USD","LU0234570918.USD","LU1585245621.USD","IE00B2B36J28.USD","LU0985320562.USD","LU0994945656.USD","LU0545039389.USD","LU1059921491.USD","LU1066053197.SGD","LU2471134952.CNY","LU0321505868.SGD","IE0000B7K699.USD","LU1145028129.USD","LU2430703251.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","IXJ","LU0306807586.USD","SG9999002224.SGD","LU1074936037.SGD","LU2756315318.SGD","LU1244550221.USD","IE00BFXG1179.USD","LU2430703095.HKD","LU0792757196.USD","SG9999003800.SGD","LU0889566641.SGD","IE0001KFT4U8.USD","LU1196500208.SGD","LU0225771236.USD","LU2129689431.USD","LU0289739343.SGD","JNJ","RXL","BK4139","IE00BKVL7J92.USD","IE00BLSP4239.USD","IDNA","LU2468319806.SGD","GNOM","IE00BLSP4452.SGD","LU2213496289.HKD","LU0345770993.USD","SGXZ80539844.SGD","LU1066051811.HKD","BK4007","LU0122379950.USD","LU1221951046.USD","LU0511384066.AUD","LU1674673428.USD","IE00BN8TJ469.HKD","LU0289739699.SGD","BK4568","IE00BVYPNW00.USD","LU1244550577.SGD","LU0820561818.USD","PJP","LGHT","LU1043141123.HKD","LU1732800096.USD","LU2596442595.SGD","LU0472753341.HKD","LU1061106388.HKD","LU0466842654.USD","LU0426412945.USD","LU0545562505.USD","LU2417539215.USD","BK4548","LU0964807845.USD","LU1894683348.USD","LU2505996681.GBP","LU1261432733.SGD","LU0057025933.USD","IE00BJJMRZ35.SGD","LU0795875086.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671013268","title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Sells USD 743,436 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2671013268","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671013268?lang=en_us&edition=fundamental","pubTime":"2026-09-29 06:00","pubTimestamp":1790632843,"startTime":"0","endTime":"0","summary":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sells USD 743,436 in common sharesRevolution Medicines Chief Global Commercialization Officer Anthony Mancini reported sales","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLcdFr5m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Sells USD 743,436 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE0009355771.USD","LU0109394709.USD","IE00B4R5TH58.HKD","PTH","LU0889565916.HKD","IE0009354923.USD","IE00B2B36J28.USD","BBH","IE00BJJMRZ35.SGD","BK4139","RVMD","IE00BFTCPJ56.SGD","LU0320765992.SGD","CANC","IE00BJT1NW94.SGD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}